Terms: = Brain cancer AND GATA3, HDR, 2625, ENSG00000107485, MGC5445, MGC5199, MGC2346 AND Treatment
36 results:
1. [New pathological classification and clinical implications of pituitary neuroendocrine tumors of the 2022 WHO version].
Xie J; Wu ZB
Zhonghua Yi Xue Za Zhi; 2022 Dec; 102(47):3723-3726. PubMed ID: 36517420
[TBL] [Abstract] [Full Text] [Related]
2. Patterns of genomic change in residual disease after neoadjuvant chemotherapy for estrogen receptor-positive and HER2-negative breast cancer.
Chatzipli A; Bonnefoi H; MacGrogan G; Sentis J; Cameron D; Poncet C; ; Iggo R
Br J Cancer; 2021 Nov; 125(10):1356-1364. PubMed ID: 34480095
[TBL] [Abstract] [Full Text] [Related]
3. Feasibility of removable balloon implant for simultaneous magnetic nanoparticle heating and hdr brachytherapy of brain tumor resection cavities.
Stauffer PR; Rodrigues DB; Goldstein R; Nguyen T; Yu Y; Wan S; Woodward R; Gibbs M; Vasilchenko IL; Osintsev AM; Bar-Ad V; Leeper DB; Shi W; Judy KD; Hurwitz MD
Int J Hyperthermia; 2020; 37(1):1189-1201. PubMed ID: 33047639
[TBL] [Abstract] [Full Text] [Related]
4. Pediatric meningioma: a clinicopathologic and molecular study with potential grading implications.
Toland A; McNulty SN; Pekmezci M; Evenson M; Huntoon K; Pierson CR; Boue DR; Perry A; Dahiya S
Brain Pathol; 2020 Nov; 30(6):1134-1143. PubMed ID: 32716568
[TBL] [Abstract] [Full Text] [Related]
5. Gastric and adrenal metastasis from breast cancer: Case report and review of literature.
Tang T; Zhang L; Li C; Zhou T
Medicine (Baltimore); 2020 Jan; 99(3):e18812. PubMed ID: 32011488
[TBL] [Abstract] [Full Text] [Related]
6. Highly efficient genome editing via CRISPR-Cas9 in human pluripotent stem cells is achieved by transient BCL-XL overexpression.
Li XL; Li GH; Fu J; Fu YW; Zhang L; Chen W; Arakaki C; Zhang JP; Wen W; Zhao M; Chen WV; Botimer GD; Baylink D; Aranda L; Choi H; Bechar R; Talbot P; Sun CK; Cheng T; Zhang XB
Nucleic Acids Res; 2018 Nov; 46(19):10195-10215. PubMed ID: 30239926
[TBL] [Abstract] [Full Text] [Related]
7. CT-guided interstitial hdr-brachytherapy for recurrent glioblastoma multiforme: a 20-year single-institute experience.
Chatzikonstantinou G; Zamboglou N; Archavlis E; Strouthos I; Zoga E; Milickovic N; Hilaris B; Baltas D; Rödel C; Tselis N
Strahlenther Onkol; 2018 Dec; 194(12):1171-1179. PubMed ID: 30203110
[TBL] [Abstract] [Full Text] [Related]
8. Dosimetric comparison of surface mould hdr brachytherapy with VMAT.
Boman EL; Paterson DB; Pearson S; Naidoo N; Johnson C
J Med Radiat Sci; 2018 Dec; 65(4):311-318. PubMed ID: 30105776
[TBL] [Abstract] [Full Text] [Related]
9. Experimental assessment of the Advanced Collapsed-cone Engine for scalp brachytherapy treatments.
Cawston-Grant B; Morrison H; Sloboda RS; Menon G
Brachytherapy; 2018; 17(2):489-499. PubMed ID: 29239813
[TBL] [Abstract] [Full Text] [Related]
10. Metastatic non-muscle invasive bladder cancer with meningeal carcinomatosis: case report of an unexpected response.
Teyssonneau D; Daste A; Dousset V; Hoepffner JL; Ravaud A; Gross-Goupil M
BMC Cancer; 2017 May; 17(1):323. PubMed ID: 28494780
[TBL] [Abstract] [Full Text] [Related]
11. Wwox-Brca1 interaction: role in DNA repair pathway choice.
Schrock MS; Batar B; Lee J; Druck T; Ferguson B; Cho JH; Akakpo K; Hagrass H; Heerema NA; Xia F; Parvin JD; Aldaz CM; Huebner K
Oncogene; 2017 Apr; 36(16):2215-2227. PubMed ID: 27869163
[TBL] [Abstract] [Full Text] [Related]
12. Secondary cancer-incidence risk estimates for external radiotherapy and high-dose-rate brachytherapy in cervical cancer: phantom study.
Lee B; Ahn SH; Kim H; Son J; Sung J; Han Y; Huh SJ; Kim JS; Kim DW; Yoon M
J Appl Clin Med Phys; 2016 Sep; 17(5):124-132. PubMed ID: 27685104
[TBL] [Abstract] [Full Text] [Related]
13. Delivery systems for brachytherapy.
de la Puente P; Azab AK
J Control Release; 2014 Oct; 192():19-28. PubMed ID: 25008970
[TBL] [Abstract] [Full Text] [Related]
14. Long-term followup of breast preservation by re-excision and balloon brachytherapy after ipsilateral breast tumor recurrence.
Trombetta M; Hall M; Julian TB
Brachytherapy; 2014; 13(5):488-92. PubMed ID: 24950822
[TBL] [Abstract] [Full Text] [Related]
15. Combined salvage therapies for recurrent glioblastoma multiforme: evaluation of an interdisciplinary treatment algorithm.
Archavlis E; Tselis N; Birn G; Ulrich P; Zamboglou N
J Neurooncol; 2014 Sep; 119(2):387-95. PubMed ID: 24947312
[TBL] [Abstract] [Full Text] [Related]
16. Salvage therapy for recurrent glioblastoma multiforme: a multimodal approach combining fluorescence-guided resurgery, interstitial irradiation, and chemotherapy.
Archavlis E; Tselis N; Birn G; Ulrich P; Zamboglou N
Neurol Res; 2014 Dec; 36(12):1047-55. PubMed ID: 24852696
[TBL] [Abstract] [Full Text] [Related]
17. Stereotactic iodine-125 brachytherapy for brain tumors: temporary versus permanent implantation.
Ruge MI; Kickingereder P; Grau S; Treuer H; Sturm V; Voges J
Radiat Oncol; 2012 Jun; 7():94. PubMed ID: 22713629
[TBL] [Abstract] [Full Text] [Related]
18. Novel use of the Contura for high dose rate cranial brachytherapy.
Scanderbeg DJ; Alksne JF; Lawson JD; Murphy KT
Med Dosim; 2011; 36(4):344-6. PubMed ID: 21144735
[TBL] [Abstract] [Full Text] [Related]
19. Optimization and it's influence on value of doses in hdr and PDR brachytherapy.
Skowronek J; Zwierzchowski G; Piotrowski T; Milecki P
Neoplasma; 2010; 57(4):369-76. PubMed ID: 20429630
[TBL] [Abstract] [Full Text] [Related]
20. Values of biologically equivalent doses in healthy tissues: comparison of PDR and hdr brachytherapy techniques.
Skowronek J; Malicki J; Piotrowski T
Brachytherapy; 2010; 9(2):165-70. PubMed ID: 19879813
[TBL] [Abstract] [Full Text] [Related]
[Next]
